RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43

[1]  A. Gitler,et al.  Pour Some Sugar on TDP(-43). , 2018, Molecular cell.

[2]  R. Kalb,et al.  Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization. , 2018, Molecular cell.

[3]  C. van Broeckhoven,et al.  ALS Genes in the Genomic Era and their Implications for FTD. , 2018, Trends in genetics : TIG.

[4]  P. Tomançak,et al.  RNA buffers the phase separation behavior of prion-like RNA binding proteins , 2018, Science.

[5]  Seung Joong Kim,et al.  Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites , 2018, Cell.

[6]  Julie C. Sung,et al.  Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains , 2018, Cell.

[7]  E. L. Guenther,et al.  Atomic-level evidence for packing and positional amyloid polymorphism by segment from TDP-43 RRM2 , 2018, Nature Structural & Molecular Biology.

[8]  E. Feldman,et al.  Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization , 2018, bioRxiv.

[9]  Nicolas L. Fawzi,et al.  A single N‐terminal phosphomimic disrupts TDP‐43 polymerization, phase separation, and RNA splicing , 2018, The EMBO journal.

[10]  C. Brangwynne,et al.  Liquid phase condensation in cell physiology and disease , 2017, Science.

[11]  F. Allain,et al.  Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation , 2017, Nature Communications.

[12]  D. Laurents,et al.  Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions , 2017, The Journal of Biological Chemistry.

[13]  J. Shorter,et al.  RNA-binding proteins with prion-like domains in health and disease. , 2017, The Biochemical journal.

[14]  David A. Knowles,et al.  Therapeutic reduction of ataxin 2 extends lifespan and reduces pathology in TDP-43 mice , 2017, Nature.

[15]  Jeffrey J. Nirschl,et al.  Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons , 2017, Proceedings of the National Academy of Sciences.

[16]  A. Chakrabartty,et al.  Phase to Phase with TDP-43. , 2017, Biochemistry.

[17]  Jared E. Toettcher,et al.  Spatiotemporal Control of Intracellular Phase Transitions Using Light-Activated optoDroplets , 2017, Cell.

[18]  E. Buratti,et al.  TDP-43 aggregation mirrors TDP-43 knockdown, affecting the expression levels of a common set of proteins , 2016, Scientific Reports.

[19]  Nicolas L. Fawzi,et al.  ALS Mutations Disrupt Phase Separation Mediated by α-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain. , 2016, Structure.

[20]  R. Rohatgi,et al.  In Vivo Formation of Vacuolated Multi-phase Compartments Lacking Membranes. , 2016, Cell reports.

[21]  P. van Damme,et al.  Inside out: the role of nucleocytoplasmic transport in ALS and FTLD , 2016, Acta Neuropathologica.

[22]  M. Kinjo,et al.  Interaction of RNA with a C-terminal fragment of the amyotrophic lateral sclerosis-associated TDP43 reduces cytotoxicity , 2016, Scientific Reports.

[23]  Peter Tompa,et al.  Polymer physics of intracellular phase transitions , 2015, Nature Physics.

[24]  Erin M. Langdon,et al.  RNA Controls PolyQ Protein Phase Transitions. , 2015, Molecular cell.

[25]  A. Kanagaraj,et al.  Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization , 2015, Cell.

[26]  Sean J. Miller,et al.  The C9orf72 repeat expansion disrupts nucleocytoplasmic transport , 2015, Nature.

[27]  Bruce L. Miller,et al.  GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport , 2015, Nature.

[28]  J. Rothstein,et al.  Rodent Models of Amyotrophic Lateral Sclerosis , 2015, Current protocols in pharmacology.

[29]  C. Brangwynne,et al.  The disordered P granule protein LAF-1 drives phase separation into droplets with tunable viscosity and dynamics , 2015, Proceedings of the National Academy of Sciences.

[30]  Timothy D. Craggs,et al.  Phase Transition of a Disordered Nuage Protein Generates Environmentally Responsive Membraneless Organelles , 2015, Molecular cell.

[31]  C. Shaw,et al.  TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets , 2015, Neurotherapeutics.

[32]  C. Yip,et al.  Binding of TDP-43 to the 3'UTR of its cognate mRNA enhances its solubility. , 2014, Biochemistry.

[33]  Justin D. Vrana,et al.  An optimized optogenetic clustering tool for probing protein interaction and function , 2014, Nature Communications.

[34]  Chunxing Yang,et al.  TDP-43—The key to understanding amyotrophic lateral sclerosis , 2014, Rare diseases.

[35]  J. Trojanowski,et al.  Therapeutic modulation of eIF2α-phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models , 2013, Nature Genetics.

[36]  S. Lorenzl,et al.  Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations , 2013, Acta Neuropathologica.

[37]  D. Cleveland,et al.  Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis , 2013, Neuron.

[38]  C. van Broeckhoven,et al.  Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD–ALS spectrum disorders , 2013, Human molecular genetics.

[39]  M. Myers,et al.  Characterizing TDP-43 interaction with its RNA targets , 2013, Nucleic acids research.

[40]  Rebecca B. Smith,et al.  RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. , 2013, Human molecular genetics.

[41]  Gene W. Yeo,et al.  ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43 , 2013, Proceedings of the National Academy of Sciences.

[42]  B. Wolozin,et al.  TDP-43: A new player on the AD field? , 2012, Experimental Neurology.

[43]  Tai-Huang Huang,et al.  The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity. , 2012, Biochemical and biophysical research communications.

[44]  C. Haass,et al.  Requirements for Stress Granule Recruitment of Fused in Sarcoma (FUS) and TAR DNA-binding Protein of 43 kDa (TDP-43)* , 2012, The Journal of Biological Chemistry.

[45]  T. Hortobágyi,et al.  p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS , 2011, Acta Neuropathologica.

[46]  R. Baloh.  TDP‐43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration , 2011, The FEBS journal.

[47]  J. Kril,et al.  Cytoplasmic Accumulation and Aggregation of TDP-43 upon Proteasome Inhibition in Cultured Neurons , 2011, PloS one.

[48]  Jernej Ule,et al.  TDP‐43 regulates its mRNA levels through a negative feedback loop , 2011, The EMBO journal.

[49]  M. Ehlers,et al.  Rapid blue light induction of protein interactions in living cells , 2010, Nature Methods.

[50]  Brandon E Gavett,et al.  TDP-43 Proteinopathy and Motor Neuron Disease in Chronic Traumatic Encephalopathy , 2010, Journal of neuropathology and experimental neurology.

[51]  John Q. Trojanowski,et al.  Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS , 2010, Nature.

[52]  E. Buratti,et al.  TDP‐43 is recruited to stress granules in conditions of oxidative insult , 2009, Journal of neurochemistry.

[53]  A. Hyman,et al.  Germline P Granules Are Liquid Droplets That Localize by Controlled Dissolution/Condensation , 2009, Science.

[54]  L. Petrucelli,et al.  Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity , 2009, Proceedings of the National Academy of Sciences.

[55]  P. Kuo,et al.  Structural insights into TDP-43 in nucleic-acid binding and domain interactions , 2009, Nucleic acids research.

[56]  P. Anderson,et al.  Stress granules: the Tao of RNA triage. , 2008, Trends in biochemical sciences.

[57]  Ed Hurt,et al.  Exporting RNA from the nucleus to the cytoplasm , 2007, Nature Reviews Molecular Cell Biology.

[58]  F. Edwards,et al.  Differential development of neuronal physiological responsiveness in two human neural stem cell lines , 2007, BMC Neuroscience.

[59]  M. Rexach,et al.  Natively Unfolded Nucleoporins Gate Protein Diffusion across the Nuclear Pore Complex , 2007, Cell.

[60]  Murray Grossman,et al.  TDP-43-Positive White Matter Pathology in Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions , 2007, Journal of neuropathology and experimental neurology.

[61]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[62]  D. Handy,et al.  The Short N-terminal Domains of STIM1 and STIM2 Control the Activation Kinetics of Orai1 Channels* , 2006, The Journal of Biological Chemistry.

[63]  Francisco E. Baralle,et al.  Characterization and Functional Implications of the RNA Binding Properties of Nuclear Factor TDP-43, a Novel Splicing Regulator ofCFTR Exon 9* , 2001, The Journal of Biological Chemistry.

[64]  J. Williamson.  Induced fit in RNA–protein recognition , 2000, Nature Structural Biology.

[65]  J. Buchan,et al.  Stress Granules and ALS: A Case of Causation or Correlation? , 2018, Advances in neurobiology.